Please login to the form below

Not currently logged in
Email:
Password:

pain treatment

This page shows the latest pain treatment news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s uterine fibroids drug aces second phase III trial

AbbVie’s uterine fibroids drug aces second phase III trial

The two companies are currently waiting for an FDA verdict in the US in the coming weeks on elagolix as a treatment for endometriosis-related pain, but uterine fibroids are another ... The results from this study demonstrate elagolix has the potential to

Latest news

  • Teva to cut 7000 jobs, close 15 manufacturing sites Teva to cut 7000 jobs, close 15 manufacturing sites

    He said Teva's women's health and European cancer and pain-treatment division are candidates to be divested and would help the company raise $2bn in proceeds, higher than an

  • Grünenthal buys Zomig rights as AZ slimming drive continues Grünenthal buys Zomig rights as AZ slimming drive continues

    Mark Mallon, EVP, global product and portfolio strategy at AstraZeneca, said: “Grünenthal is an established partner with expertise in the treatment of pain. ... Gabriel Baertschi, CEO of Grünenthal, said: “The acquisition of the

  • UK site a casualty as Pfizer reduces pain R&D UK site a casualty as Pfizer reduces pain R&D

    operations. It also signals a reduced investment by Pfizer in pain research, which has proved a tough challenge for pharma companies. ... pain treatment tanezumab, which is in phase III trials.

  • Grunenthal and AcelRx’s Zalviso approved in EU Grunenthal and AcelRx’s Zalviso approved in EU

    Grunenthal and AcelRx’ s Zalviso approved in EU. Provides new treatment for post-operative pain. ... Within the European Union there are around 19 million surgical procedures with post-operative pain and a recent German survey found that 55% of

  • Shire and Baxalta drugs among CHMP's latest recommendations Shire and Baxalta drugs among CHMP's latest recommendations

    Keryx Biopharma's Fexeric (ferric citrate coordination complex) for the treatment of hyperphosphataemia in adults with chronic kidney disease . • ... Grunenthal's Zalviso (sufentanil) for the treatment of post-operative pain. A hybrid medicine,

More from news
Approximately 2 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • Mobile health and patient outcomes Mobile health and patient outcomes

    Healthcare professionals, scientists and pharmaceutical companies’understanding of the daily impact of disease and treatment on a person’s life are not always as good as they could be. ... In a recent study in rheumatoid arthritis, patients saw pain

  • Deal Watch - May 2017 Deal Watch - May 2017

    The acquisition provides Innocoll with the financial resources to continue the development of its bupivacaine collagen implant for treatment of post-operative pain. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in

  • Deal Watch February 2017 Deal Watch February 2017

    Cynosure's portfolio of more than 20 products covers areas such as non-invasive body contouring (including SculpSure, an FDA approved laser treatment for body contouring), hair removal, skin revitalisation and ... Combined the five products cover eight

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Cara Therapeutics has a chronic pain treatment based on a peptide that is rendered orally bioavailable using Enteris Biopharma's Peptelligence platform, which combines a permeation enhancer and a calcium chelator ... As the intestines don't have sharp

  • Pharma deals in June 2015 Pharma deals in June 2015

    solutions, which includes hospital beds, wound treatment systems, respiratory care and surgical equipment. ... Licence, collaboration. 364. Spinifex Pharmaceuticals/ Novartis. Lead candidate EMA401 - oral treatment for chronic pain, particularly

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Virtual reality—a change for the better in medical education

    VR’ s usefulness in cancer treatment doesn’ t just extend into pain management. ... The impact of virtual reality distraction on pain and anxiety during dental treatment in 4– 6 year-old children: a randomized controlled clinical trial.

  • THE OTHER SIDE OF … GOUT

    Doctors’ goals, on the other hand, seem to be lower. “ Keep doing what you are doing”, they tell Jan when she complains about her pain, continuing to prescribe the same treatment. ... work to shift beliefs and increase motivation to improve care

  • 6 things that doctors want

    Doctors want a stronger collaboration with industry with the objective of raising the quality of patient care and improving treatment outcomes.What this means is that the barriers to healthcare professional ... adherence conditions like hypertension–

  • Research Partnership

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... Barriers to Biologic Treatment - Is Injecting Such a Pain?.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics